Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis

BMC Psychiatry
Ulysses S TorresGeraldo F Busatto

Abstract

The results of multiple studies on the association between antipsychotic use and structural brain changes in schizophrenia have been assessed only in qualitative literature reviews to date. We aimed to perform a meta-analysis of voxel-based morphometry (VBM) studies on this association to quantitatively synthesize the findings of these studies. A systematic computerized literature search was carried out through MEDLINE/PubMed, EMBASE, ISI Web of Science, SCOPUS and PsycINFO databases aiming to identify all VBM studies addressing this question and meeting predetermined inclusion criteria. All studies reporting coordinates representing foci of structural brain changes associated with antipsychotic use were meta-analyzed by using the activation likelihood estimation technique, currently the most sophisticated and best-validated tool for voxel-wise meta-analysis of neuroimaging studies. Ten studies (five cross-sectional and five longitudinal) met the inclusion criteria and comprised a total of 548 individuals (298 patients on antipsychotic drugs and 250 controls). Depending on the methodologies of the selected studies, the control groups included healthy subjects, drug-free patients, or the same patients evaluated repeatedly in lon...Continue Reading

References

Oct 1, 1991·Schizophrenia Research·G DegreefJ Lieberman
May 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·P Jones, R M Murray
Jun 1, 1985·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·L E DeLisiM S Buchsbaum
Jul 1, 1987·Archives of General Psychiatry·D R Weinberger
Mar 1, 1995·Archives of General Psychiatry·R J Baldessarini, A C Viguera
Mar 1, 1994·Journal of Computer Assisted Tomography·D L CollinsA C Evans
Apr 1, 1996·The American Journal of Psychiatry·J A FrazierJ L Rapoport
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·S M Lawrie, S S Abukmeil
May 20, 1999·Biological Psychiatry·R W McCarleyM E Shenton
Jan 5, 2000·The American Journal of Psychiatry·I C WrightE T Bullmore
Jun 22, 2000·NeuroImage·J Ashburner, K J Friston
Nov 4, 2000·The British Journal of Psychiatry : the Journal of Mental Science·P F LiddleE T Ngan
Mar 21, 2001·Biological Psychiatry·J LiebermanR Bilder
May 10, 2001·Schizophrenia Research·M E ShentonR W McCarley
Jan 5, 2002·The New England Journal of Medicine·John G CsernanskyUNKNOWN Risperidone-USA-79 Study Group
Jun 5, 2002·Archives of General Psychiatry·Daniel R Weinberger, Robert K McClure
Jun 8, 2002·Annual Review of Neuroscience·David A Lewis, Pat Levitt
Aug 10, 2002·NeuroImage·Peter E TurkeltaubThomas A Zeffiro
Nov 7, 2002·Archives of General Psychiatry·Wiepke CahnRené S Kahn
Jan 7, 2003·Archives of General Psychiatry·Herbert Y MeltzerUNKNOWN International Suicide Prevention Trial Study Group
Aug 16, 2003·Journal of Clinical Psychopharmacology·Christian R DolderDilip V Jeste
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Herbert Y MeltzerJunji Ichikawa
Apr 3, 2004·Nature Reviews. Drug Discovery·Bryan L RothWesley K Kroeze
Jul 29, 2004·Schizophrenia Bulletin·Martin KnappJudit Simon
Sep 2, 2004·Molecular Psychiatry·C A Tamminga, H H Holcomb
Sep 17, 2004·Cerebral Cortex·Katherine L NarrPaul M Thompson
Feb 9, 2005·Molecular Psychiatry·J L RapoportM R C Psych

❮ Previous
Next ❯

Citations

Jul 15, 2015·Expert Opinion on Emerging Drugs·Jonathan Tomas Lockwood, Gary Remington
Mar 21, 2015·European Psychiatry : the Journal of the Association of European Psychiatrists·J MoilanenJ Miettunen
Aug 28, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Eric PlitmanAriel Graff-Guerrero
Aug 8, 2015·The Journal of Nervous and Mental Disease·Yuqing SongCharles Zaroff
Mar 7, 2015·Brain Imaging and Behavior·Vanessa DouetUNKNOWN Pediatric Imaging, Neurocognition, and Genetics (PING) Consortium
Aug 28, 2016·Psychiatry Research·Vijay KumarBangalore N Gangadhar
Oct 27, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Henrik Nørbak-EmigBjørn H Ebdrup
Apr 30, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Martin Jáni, Tomáš Kašpárek
Jan 8, 2015·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Kelly K AndersonKwame J Mckenzie
Aug 23, 2018·Frontiers in Psychiatry·Anne B KoopmansPeter N van Harten
Apr 4, 2017·Human Psychopharmacology·Sanna HuhtaniskaJouko Miettunen
Oct 16, 2018·Clinical Psychological Science : a Journal of the Association for Psychological Science·Derek J DeanVijay A Mittal
Feb 7, 2021·Experimental Neurology·Alexandra I KordaStefan Borgwardt
Feb 26, 2021·Translational Psychiatry·Anne B KoopmansPeter N van Harten

❮ Previous
Next ❯

Software Mentioned

icbm2tal
Mango
GingerALE
ALE

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here